Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Condensed Consolidated Statements of Operations and Comprehensive Loss
Collaboration revenues	$ 19,530	$ 4,896
Operating expenses:
Research and development	34,864	32,211
General and administrative	16,382	14,488
Total operating expenses	51,246	46,699
Loss from operations	(31,716)	(41,803)
Other income (expense):
Interest income	5,624	2,929
Interest expense	(821)	(808)
Total other income (expense), net	4,803	2,121
Net loss before income tax provision	(26,913)	(39,682)
Benefit from income taxes	(350)	(618)
Net loss	$ (26,563)	$ (39,064)
Net loss per share, basic	$ (0.62)	$ (1.30)
Net loss per share, diluted	$ (0.62)	$ (1.30)
Weighted average ordinary shares outstanding, basic	42,560,091	30,001,725
Weighted average ordinary shares outstanding, diluted	42,560,091	30,001,725
Comprehensives loss:
Net Income (Loss)	$ (26,563)	$ (39,064)
Other comprehensive income:
Foreign currency translation adjustment	526	(316)
Total comprehensive loss	$ (26,037)	$ (39,380)